Development of an AQbD-guided sustainable RP-HPLC method for simultaneous quantification of saracatinib and rapamycin in lipid–polymer hybrid nanocarriers
To develop a sustainable RP-HPLC method guided by AQbD for the simultaneous quantification of saracatinib and rapamycin.
Utilized AQbD framework for method development.
Employed RP-HPLC for analysis of samples.
Focused on lipid-polymer hybrid nanocarriers as a delivery system.
Achieved successful simultaneous quantification of saracatinib and rapamycin.
Demonstrated method sustainability and efficiency in analytical processes.
Abstract
AQbD-guided sustainable RP-HPLC enables simultaneous quantification of saracatinib and rapamycin in lipid–polymer hybrid nanocarriers.
اسأل الذكاء الاصطناعي
Like
Bookmark
Share
View Full Paper
اسأل الذكاء الاصطناعي
Like
Bookmark
Share
View Full Paper
Development of an AQbD-guided sustainable RP-HPLC method for simultaneous quantification of saracatinib and rapamycin in lipid–polymer hybrid nanocarriers | Synapse